Publication:
MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approval

Simple item page
dc.contributor.authorThanyanan Reungwetwattanaen_US
dc.contributor.authorSai Hong Ignatius Ouen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUCI School of Medicineen_US
dc.date.accessioned2018-11-23T11:04:44Z
dc.date.available2018-11-23T11:04:44Z
dc.date.issued2015-01-01en_US
dc.identifier.citationTranslational Lung Cancer Research. Vol.4, No.6 (2015), 820-824en_US
dc.identifier.doi10.3978/j.issn.2218-6751.2015.12.03en_US
dc.identifier.issn22264477en_US
dc.identifier.issn22186751en_US
dc.identifier.other2-s2.0-84960130558en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/36805
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84960130558&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleMET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approvalen_US
dc.typeNoteen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84960130558&origin=inwarden_US

Files

Collections

Scopus 2011-2015